From the 2022 Joint Annual
Meeting (recorded 6/27/2022)
Presented by Jeremy
Prokop, PhD and Linda Rossetti, MD, FACMG
We will discuss the current
state of rare disease sequencing, both clinically and research. This will
include a discussion of state wide initiatives, additional omic data
integrations, and characterization of difficult variants.
LEARNING OBJECTIVES
At the conclusion of this presentation,
participants will be able to:
- Identify the current state of WGS clinical sequencing
- Summarize the growth of new research directions for rare diseases
- Summarize how variant reclassifications can be performed
CE ACCREDITATION
ASCLS is approved as a provider of continuing
education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ®
Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the
area of Molecular Biology (Molecular) will
be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT
Board of Certification and all states, including Florida and California, as an
approved provider of continuing education for recertification and licensure.
ASCLS is an approved provider with CE Broker for Florida licensees.
LEVEL OF INSTRUCTION
This Advanced-level
program is appropriate for laboratory professionals working in clinical, public
health and academic settings.